Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0425
-0.0020 (-4.49%)
Dec 17, 2025, 3:59 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $12.72 million as of December 17, 2025. Its market cap has decreased by -93.10% in one year.
Market Cap
12.72M
Enterprise Value
35.34M
Revenue
65.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 12.72M, a decrease of -98.96%. That is a compound annual growth rate of -34.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 12.72M | -90.77% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | 834.26M | 561.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 537.07M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 396.23M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |